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The Effect of Hypoxia and Work Intensity on Insulin
Resistance in Type 2 Diabetes
R. Mackenzie, B. Elliott, N. Maxwell, G. Brickley, and P. Watt
School of Life Sciences (R.M., B.E.), University of Westminster, London W1W 6UW, United Kingdom;
and Chelsea School Research Centre (N.M., G.B., P.W.), University of Brighton, Eastbourne BN20 7SR,
United Kingdom
Context:Hypoxia andmuscle contraction stimulate glucose transport in vitro. We have previously
demonstrated that exercise and hypoxia have an additive effect on insulin sensitivity in type 2
diabetics.
Objectives: Our objective was to examine the effects of three different hypoxic/exercise (Hy Ex)
trials on glucose metabolism and insulin resistance in the 48 h after acute hypoxia in type 2
diabetics.
Design, Participants, and Interventions: Eight male type 2 diabetics completed 60 min of hypoxic
[mean (SEM) O2  14.7 (0.2)%] exercise at 90% of lactate threshold [Hy Ex
60; 49 (1) W]. Patients
completed an additional two hypoxic trials of equal work, lasting 40 min [Hy Ex40; 70 (1) W] and
20 min [Hy Ex20; 140 (12) W].
MainOutcomeMeasures:Glucose rate of appearance and rate of disappearancewere determined
using the one-compartment minimal model. Homeostasis models of insulin resistance (HOMAIR),
fasting insulin resistance indexand-cell function (HOMA-cell)were calculatedat 24and48hafter
trials.
Results: Peak glucose rate of appearance was highest during Hy Ex20 [8.89 (0.56) mg/kg  min, P
0.05]. HOMAIR and fasting insulin resistance index were improved in the 24 and 48 h after Hy Ex
60
and Hy Ex40 (P  0.05). HOMAIR decreased 24 h after Hy Ex
20 (P  0.05) and returned to baseline
values at 48 h.
Conclusions: Moderate-intensity exercise in hypoxia (Hy Ex60 and Hy Ex40) stimulates acute- and
moderate-term improvements in insulin sensitivity that were less apparent in Hy Ex20. Results
suggest that exercise duration and not total work completed has a greater influence on acute and
moderate-term glucose control in type 2 diabetics. (J Clin Endocrinol Metab 97: 0000–0000, 2012)
The current recommendations for general health in in-dividuals with type 2 diabetes are equivalent to 30
min ofmoderate-intensity exercise daily (1, 2). Adherence
to these guidelines remains low (3) with suggestions that
30 min of moderate-intensity exercise [50% of maximal
oxygen consumption V˙O2max] has little effect on glucose
tolerance in type 2 diabetic patients (4). We recently dem-
onstrated that 60 min of exercise at approximately 50%
V˙O2max [90% lactate threshold (LT)] improves insulin
sensitivity in type 2 diabetics (5). However, 60 min of
exercise may not be an obtainable goal for diabetics. The
possibility that an equivalent or greater effect (i.e. glucose
clearance) could occur using shorter exercise durations of
similar workload would therefore have clear clinical
benefits.
Using identical exercise durations (50 vs. 70% V˙O2max
for 20 min), Hayashi et al. (6) demonstrated that glucose
effectiveness was improved after exercise at 70% V˙O2max
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but not at 50% V˙O2max, suggesting total work and energy
expenditure are key factors in contraction-stimulated im-
provements in glucose control. Counter to this, Kraniou et
al. (7) demonstrated that exercise at two different inten-
sities and durations (40% V˙O2max for 60 min vs. ap-
proximately 80% V˙O2maxfor 27 min), but of equal
work, increased glucose transporter (GLUT)-4 expression
in nondiabetic skeletalmuscle to a similar degree, but only
high-intensity exercise lowered muscle glycogen content.
This latter finding indicates that high-intensity exercise
has a greater ability to encourage postexercise glycogen
resynthesis, suggesting that total work, and not exercise
intensity or duration, is the significant contributing factor
in glucose transport activity.
Contractile activity and hypoxia are known to stimu-
late glucose uptake in skeletal muscle via Ca2/AMP-ac-
tivated protein kinase (AMPK) (contraction)-dependent
pathway (8–10) that remains largely intact in type 2 dia-
betes (11).After exercise, improvements inglucose control
are largely dependent on insulin-stimulated glucose trans-
port (12). We have shown that moderate-intensity nor-
moxic exercise and resting hypoxic exposure improve in-
sulin sensitivity in type 2 diabetics (5). In addition, this
improvement is augmentedwhenexercise andhypoxia are
combined (5). Thus, any intervention that has the poten-
tial to improve glucose controls warrants further investi-
gation. It now seems logical to examine whether manip-
ulating the exercise/hypoxic stimuli results in further
changes in insulin sensitivity. The aim of the present study
was therefore to identifywhether exercise intensity affects
insulin sensitivity after hypoxic exercise in type 2 diabetic
individuals. To accomplish this aim, totalwork completed
was kept constant during three hypoxia/exercise (Hy Ex)
trials of different duration.
Subjects and Methods
Eight sedentarymales, diagnosedwith type 2 diabetes within the
previous 5 yr by a general practitioner were recruited for this
investigation. Subjects’ clinical characteristics are presented in
Table 1. Ethical approval was granted by East Sussex Local Re-
search Ethics (United Kingdom). Written and verbal explana-
tions of the study design were provided before written informed
consent was obtained. Exclusion criteria included diabetic-re-
lated complications (i.e. neuropathy and peripheral vascular and
cardiovascular disease), current smokers, or treatment with in-
sulin. Five subjectswerediet treated; the remaining three subjects
were treated with metformin (n  2, metformin 500 mg three
times per day; n  1, metformin 500 mg once per day). Three
individuals were also being treated for hypertension [calcium
channel blockers (5–10mg twice daily)]. Subjects requiringmet-
forminwere asked to abstain frommedication in the 48 h before
experimental trials. Metformin has a whole-blood specific half-
life of approximately 17.6 h (13).
Experimental design
Study design was based on four visits. The first visit enabled
the collection of preliminary data and to obtain individual LT
values under normoxic conditions. Thereafter, subjects returned
to complete three exercise trials in hypoxia [O2 14.7 (0.2)%]
separated by a minimum of 7 d. After each exercise trial (d 1),
subjects returned to the laboratory 24 h (d 2) and 48 h (d 3) later
for the measurement of glucose kinetics and glycemic control.
Subjects refrained from exhaustive exercise andmaintained sim-
ilar lifestyles activities throughout the experimental protocol.
Nutritional intake (Compeat version 6, UK) and calorie expen-
diture (pedometers; Sports-Tech, UK) were recorded over the
3-days of each experimental trial (14). Instructionswere given to
avoid caffeine and alcohol in the 24 h preceding and during
experimental trials.
Preliminary testing
Methodology was as previously described (5). Briefly, per-
centage of body fat was estimated using bioelectrical impedance
analysis (Bodystat, UK). Venous blood samples were drawn for
the determination of glycosylated hemoglobin (Axis-Shields Di-
agnostics, UK), fasting blood glucose (YSI 2300 STAT; YSI, Yel-
low Springs, OH), and plasma insulin concentrations (ELISA;
DRGDiagnostics, UK), for the estimation of homeostasis model
of insulin resistance [HOMAIR; fasting insulin (microunits per
milliliter)  fasting glucose (millimoles per liter)/22.5] and
HOMA of -cell function [HOMA-cell; 20  fasting insulin
(microunits per milliliter)/fasting glucose  3.5 (millimoles per
liter)] (15). LT was determined on an electrically braked Lode
cycle ergometer (Lode B.V., The Netherlands) using an incre-
mental protocol starting at 0 W with 10-W increments every 3
min. Cadence remained constant throughout (60 rpm). Fin-
gertip blood samples were collected at the end of each stage for
analysis of blood lactate concentrations [La] (YSI 2300 STAT).
LT was defined as the power output preceding a sudden, sus-
tained increase in lactate concentration (1 mmol/liter above
previous stage) and confirmed by three objective physiologists.
Determination of exercise intensity
Trial one consisted of continuous exercise for 60min at 90%
ofpredeterminedLT[HyEx60mean (SEM); 49 (4)W].Totalwork
completed was calculated and used to determine the intensity
and duration for equal work to be completed in the next two
TABLE 1. Subjects’ clinical, physiological, and metabolic characteristics
Age
(yr)
BMI
(kg/m2)
Waist
circumference (cm)
Body
fat (%)
HbA1c
(%)
Fasting glucose
(mmol/liter) HOMAIR
HOMA-cell
(%)
57.5 (2.3) 29.2 (2.9) 113.6 (6.7) 37.2 (3.8) 7.3 (0.3) 7.5 (0.5) 5.0 (1.2) 72.5 (13.7)
Values are means (SEM). BMI, Body mass index; HbA1c, glycosylated hemoglobin.
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exercise trials. Subsequently, subjects completed two bouts of
exercise lasting40min [HyEx40; 70 (9)W] and20min [HyEx20;
140 (12) W] in a randomized order.
Experimental protocol (d 1)
Subjects reported at approximately 0800 h, having fasted for
12 h. Each exercise trial (Hy Ex60, Hy Ex40, andHy Ex20) acted as
d 1.On arrival, one 18-gauge cannulawas positioned into a dorsal
hand vein for frequent sampling of arterialized blood (60 C) (5).
A second 18-gauge cannula was placed into a contralateral ante-
cubital vein for steady rate [6,6-2H2]glucose infusion (Cambridge
Isotope Laboratories Inc., Andover, MA). Whole-body hypoxia
[O2 14.7 (0.2)%] was administered using air-processing units
(SQ-10; Colorado Altitude Training, Boulder, CO) with a steady
flow of nitrogen (N2 40 liters/min) into a closed environment
[temperature of 20 (0.9) C and relative humidity of 41 (25)%].
Exercise/hypoxic trials
Glucose solutions were prepared on themorning of each trial
under sterile conditions after which a glucose bolus (40 ml) con-
taining 304 mg [6,6-2H2]glucose was injected over a 45-sec pe-
riod using an antecubital vein. A 30-min constant infusion (VP
5000;Medical Systems, Arcomedical Infusions Ltd., Essex, UK)
followed at a rate of 5.1 mg/min. Arterialized samples were
drawn every 5 min during this period. Subjects were then ex-
posed to hypoxia where they performed exercise trials. Infusion
rates were increased to 20mg/min during exercise (16). Subjects
remained in this environment for 60 min during each trial. Ar-
terialized blood samples (10 ml) were drawn every 10 min.
Heart rate (Polar Electro Oy, Kemple, Finland) and oxygen sat-
uration (Nonin 2500; Nonin, Minneapolis, MN), using a pulse
oximeter, were measured every 10 min.
Day 2
After a second consecutive overnight fast, subjects arrived
24 h (1000 h) after hypoxic exercise. Volunteers were cannu-
lated and basal arterialized samples collected at 15 and 30
min before the administration of a primed constant infusion (de-
scribed above) at a rate of 6 mg/min. Subjects rested while ar-
terialized samples (10ml) were drawn at 10-min intervals over
60min and immediately analyzed in duplicate for blood glucose.
Remaining samples were centrifuged and plasma stored at80
C for later analysis. Day 3 required subjects to arrive at the
laboratory after an additional overnight fast for the collection of
a 10-ml resting blood sample. Isotope infusion procedures were
not repeated for day 3. Control procedures set out for day 1were
repeated in the 24 and 48 h after each trial. Fasting blood glucose
and plasma insulin taken at day 1, 2, and 3were used to calculate
HOMAIR,HOMA-cell, quantitative insulin sensitivity check in-
dex [QUICKI; 1/(log fasting insulin (microunits per milliliter)
log glucose (milligrams per deciliter)] and fasting insulin resis-
tance index [FIRI; fasting glucose (millimoles per liter) fasting
insulin (milliunits per liter)/25] (15). These indices have been
validated against the one-compartment model (iv glucose toler-
ance test; r 0.79; P 0.0001) (18) and the euglycemic-hyper-
insulinemic clamp technique (15, 19).
Glucose rate of appearance (Ra), rate of
disappearance (Rd), and metabolic clearance rates
(MCR)
For [6,6-2H2]glucose enrichments, approximately 20 l
plasma was deproteinized with 100 l ethanol and centrifuged
(6000 rpm, 5 min). Supernatants were then dried for derivati-
zation, and 100 l hydroxylamine-pyridine (25 mg/ml) solution
was added and incubated for 60 min at 70 C. Subsequently, 100
l 99% bis(trimethyl)trifluoroacetamide/1% 2,3,5,6-tetra-
chloro-4-methylsulphonyl (Sigma-Aldrich, Exeter, UK) was
added to samples before anadditional 45-min incubationperiod.
Glucose was analyzed by gas chromatography mass spectrom-
eter (Clarus 500; PerkinElmer, Waltham, MA) for peaks of 319
(tracee) and 321 ([6,6-2H2]glucose; tracer). Glucose Ra, Rd, and
MCRwere estimatedusing anon-steady-state one-compartment
adapted model (20, 21) and were calculated at baseline (d 1),
during hypoxic/exercise treatments, and for rest during d 2:
C  Cm/(1  IE) (1)
Ra(t) 
ft V · Ct ·
dIEt
dt
IEt
(2)
Rd  Ra  V [(C2  C1)/(t2  t1)] (body weight1) (3)
MCR  Rd/[(C1  C2)/2], (4)
where f is isotope infusion rate, and V is the volume of distri-
bution assumed to be equal and constant (145ml/kg for glucose)
(21). The concentration (C) of the tracee at time (t) can be cal-
culated from endogenous measured concentration (Cm) of glu-
cose and enrichment at that time. C1 and C2; glucose concen-
trations and time points 1 (t1) and 2 (t2) (16). IE is the tracer
enrichment expressed as atoms percent excess at sampling times
corrected for background enrichment value determined from
basal plasma samples (22). To compensate for a known inade-
quacy of the one-compartment model, the current investigation
increased the tracer infusate content of [6,6-2H2]glucose above
that previously used (16). Increasing tracer amounts in exoge-
nous glucose infusates minimizes fluctuations in enriched sam-
ples (23).
Statistical analyses
Results are expressed as mean with SEM. Statistical significance
was set at the level P  0.05. Differences over time and between
FIG. 1. Arterialized blood lactate concentrations ([La]) during exercise.
Main-effects differences are indicated: ‡, Hy Ex60 vs. Hy Ex40, P 
0.019; *, Hy Ex60 vs. Hy Ex20, P  0.002; †, Hy Ex40 vs. Hy Ex20, P 
0.046. Values are means (SEM).
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conditions forallmeasuredandcalculatedvariableswere evaluated
by two-way repeated-measures ANOVA.Where sphericity of data
was broken, P values were corrected using the Huynh-Feldt
method, and significant differences between data points were iden-
tified using Tukey’s post hoc test (SPSS version 15).
Results
No difference was found for total kilocalorie intake, car-
bohydrate consumption, or energy expenditure both
within and between trials (P 	 0.05). Main-effect differ-
ences for arterialized blood lactate concentrations ([La])
were noted betweenHyEx60 andHyEx40 (P0.019),Hy
Ex60 and Hy Ex20 (P 0.002), and Hy Ex40 and Hy Ex20
(P  0.046, Fig. 1). Figure 2 shows mean changes in ar-
terialized blood glucose concentrations from baseline to
the end of each trial, representing the combined effects of
hypoxia and exercise. Hy Ex20 demonstrated no differ-
ence in blood glucose concentration (0.39 mmol/liter)
over the 60-min exposure. Both Hy Ex60 and Hy Ex40
caused reductions in blood glucose of 1.60 and 0.84
mmol/liter (P0.005), respectively. Time-course data for
blood glucose concentrations are presented in Fig. 3.Main
effect differences were noted between Hy Ex60 and Hy
Ex40 and between Hy Ex60 and Hy Ex20 (P  0.05). No
differencewas found for the comparison betweenHyEx40
and Hy Ex20.
GlucoseRawas greater forHyEx
20when comparedwith
Hy Ex60 during exercise at 10, 20, and 30 min (P 0.037).
Ra peaked at 8.89 (0.56)mg/kg min at the 10-min point for
Hy Ex20 (Fig. 4A). Peak Ra values for Hy Ex
60 [6.26 (0.30)
mg/kg min] andHyEx40 [6.66 (0.84)mg/kg min]occurred
at the 20 min point during exercise and were found to be
29.6% (P  0.02) and 25.1% (P  0.041) lower than Hy
Ex20, respectively.
The highest Rd for glucosewasmeasured inHyEx
20 dur-
ing the first 10min of exercise [8.35 (0.60)mg/kg  min] and
remained elevated above both Hy Ex60 (P 0.001) andHy
Ex40 (P 0.040) until 40min of exercise/hypoxia (Fig. 4B).
Rd peaked within 20 min for both Hy Ex
60 [6.44 (0.32)
mg/kg  min] andHy Ex40 [6.70 (0.79) mg/kg  min] with no
difference between conditions.MCRshowednodifference be-
tweenHyEx60 [4.89 (0.30)ml/kg min],HyEx40 [5.00 (0.26)
ml/kg min], andHyEx20 [5.04 (0.70)ml/kg min] (P	0.05).
Hypoxia/exercise for 60 min
Fasting blood glucose and plasma insulin concentrations
were lower in the 24 and 48 h (P  0.05) after 60 min of
moderate-intensity exercise in hypoxia (Hy Ex60). Indices of
insulin resistance were also improved after treatment (Table
2). Rawas not different frombaseline values taken on d1 vs.
d2 forHyEx60 [d1,1.93 (0.11)mg/kg min;d2,1.87 (0.10)
mg/kg  min]. Rd was higher in Hy Ex
60 after
exercise but did not reach significance [d 1, 1.80
(0.11)mg/kg min; d 2, 1.89 (0.12)mg/kg min].
MCR demonstrated a similar pattern [d 1, 1.49
(0.06) ml/kg  min; d 2, 1.51 (0.11) ml/kg  min]
(P	 0.05) to that of Rd.
Hypoxia/exercise for 40 min
Fastingbloodglucosewas lower24and48h
(P  0.03) after Hy Ex40 (Table 3). HOMAIR
(P 0.049) and FIRI (P 0.04) were reduced,
whereas QUICKI increased (P 0.037) in the
48 h after Hy Ex40. Glucose Ra was not altered
frombaselinevaluesafterHyEx40 [d1,2.08(0.14)
mg/kg min;d2,2.01(0.13)mg/kg min].Although
higher, Rdwas not significantly different fromval-
ues recordedond1within the same trial [d1, 1.99
(0.07) mg/kg  min; d 2, 2.10 (0.25) mg/kg  min].
FIG. 2. Mean change in arterialized blood glucose concentrations over
the 60 min of each Hy Ex trial. *, Significant difference for Hy Ex60
(P  0.001); †, Hy Ex40 (P  0.005). Bars represent means (SEM).
Individual changes are also represented by lines.
FIG. 3. Arterialized blood glucose concentrations during exercise. Main-effects
differences are indicated: *, Hy Ex60 vs. Hy Ex40; †, Hy Ex60 vs. Hy Ex20; P  0.05.
Values are means (SEM).
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Similar toHyEx60,MCRwas unchanged in the 24 h afterHy
Ex40 [d1,1.52 (0.00)ml/kg min;d2,1.55 (0.04)ml/kg min].
Hypoxia/exercise for 20 min
Improvements were shown in fasting glucose, HOMAIR,
and FIRI in the 24 h after exercise. Unlike bothHyEx60 and
HyEx40, these improvementswerenotappar-
ent on d 3 (Table 4). Glucose Ra [d 1, 1.99
(0.06) mg/kg  min; d 2, 1.91 (0.13) mg/kg 
min], Rd [d 1, 1.93 (0.08) mg/kg  min; d 2,
1.91 (0.09)mg/kg min], andMCR [d1, 1.78
(0.04)ml/kg min;d2,1.75(0.10)ml/kg min]
were not changed in the 24 h after Hy Ex20.
In addition to within-trial comparisons,
differences between Hy Ex60, Hy Ex40, and
HyEx20were also tested. Baseline values for
indices of insulin sensitivity and fasting glu-
cose and insulin were not different between
trials. In addition, fasting blood glucosewas
similar betweenHy Ex60 andHy Ex40 at d 1
[7.32 (0.67) vs. 7.37 (0.33) mmol/liter] and
d 2 [7.38 (0.69) vs. 7.66 (0.23) mmol/liter,
respectively]. Fasting insulin (P  0.028),
HOMAIR (P  0.004), QUICKI (P 
0.025), and FIRI (P  0.015) were all sig-
nificantly improved in Hy Ex60 when com-
pared with Hy Ex40 at 24 h. HOMAIR was
lower in the 48 h afterHyEx60 [3.00 (0.39)]
compared with Hy Ex40 [4.04 (0.28)] with
the other indices of insulin sensitivity being
similar between conditions at this time
point. HOMAIR was higher for Hy Ex
20
compared with Hy Ex60 in the 24 h (P 
0.01) and 48 h (P 0.044) after treatment.
All other indices were unaltered with the
same comparisons. Between-trial compari-
sons were also made for Hy Ex40 and Hy
Ex20. The data show that fasting blood glu-
cosewas lower inHyEx40 at d 2 (P0.011)
with no differences noted elsewhere.
Discussion
Thepresent studywasundertaken to investigate the effects
of three different hypoxic exercise trials, each of equal
work, on insulin resistance in the 48 h after acute hypoxic
FIG. 4. Ra (A) and Rd (B) during hypoxic exercise. ‡, Significant difference between Hy
Ex60 vs. Hy Ex40 (P  0.05); †, Hy Ex60 vs. Hy Ex20 (P  0.05); *, Hy Ex40 vs. Hy Ex20 (P 
0.05). Values are means (SEM).
TABLE 2. Fasting indices of glucose tolerance, insulin secretion, insulin sensitivity, and insulin resistance for the Hy
Ex60 trial
Hy Ex60
Glucose (mmol/liter) Insulin (U/ml) HOMAIR HOMA-cell QUICKI FIRI
d 1 8.39 (0.39) 14.58 (1.1) 4.96 (0.97) 68.7 (6.5) 0.303 (0.005) 4.73 (0.78)
d 2 7.32 (0.67)b 8.57 (1.3)b 2.48 (0.26)a 49.2 (13.9) 0.334 (0.006)b 2.47 (0.30)b
d 3 7.38 (0.69)a 11.91 (0.9)a 3.00 (0.39)a 68.6 (14.3) 0.317 (0.005)b 3.48 (0.40)a
Values are mean (SEM).
a Significantly difference from d 1 (P  0.05).
b Significantly different from d 1 (P  0.01).
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exposure in type 2 diabetics. The main findings from this
studywere that exercise in hypoxia for 60min and 40min
acutely increased glucose disposal. That Hy Ex60 im-
proved insulin sensitivity in the 48 h after exercise is con-
sistentwith our previous findings (5). In addition, shorter-
duration exercise of equal work in hypoxia (Hy Ex40)
improved moderate-term insulin resistance. Acute im-
provements in glucose control were greatest in Hy Ex60
when comparisonsweremadewithHy Ex40 andHy Ex20.
Exercise is known to increase blood glucose clearance
via augmented muscle blood flow, augmented GLUT re-
cruitment, increased substrate requirement, and elevated
insulin sensitivity (24–26). Blood glucose removal is
known to be dependent on fiber type recruitment because
type II muscle fiber, with high glycolytic capacity, creates
a greater potential for glucose disposal (27). The inability
of Hy Ex20 to reduce blood glucosemay be attributable to
an elevation in Ra resulting from high-intensity exercise
(28, 29). Hy Ex40 caused an acute reduction in blood glu-
coseduring exercisebutwas47%less thanHyEx60.Given
that Rd and MCR were similar in Hy Ex
60 and Hy Ex40,
the smaller change noted in the latter trialwould appear to
be due to a higher glucose Ra toward the end of exercise
(30). The current study suggests that higher-intensity ex-
ercise in hypoxia encourages whole-body glucose trans-
port. However, glucose concentrations remain un-
changed, or decrease moderately due to a relative increase
in endogenous glucose production (29).
Insulin sensitivity has been shown to increase by 773%
after moderate-intensity exercise in type 2 diabetics (31).
Using a two-compartmental iv glucose tolerance test, our
previous findings have shown insulin sensitivity to be in-
creased after 60 min of resting hypoxia when compared
with a normoxic control [1.39 (0.08) vs. 2.25 (0.50) 
104 min1 (U/ml), respectively]. In addition, insulin
sensitivity was also at its highest after hypoxic exercise
when comparisons were made with both normoxic rest
and normoxic exercise (5). That hypoxia and hypoxic ex-
ercise improve glucose tolerance is supported from work
carried out in animal models (9). Data presented byWad-
ley et al. (29) demonstrated that hypoxic exercise causes a
greater degree of glycogen depletion over exercise alone
[normoxic exercise; 485.0 (51.2) vs. hypoxic exercise;
371.1 (40.9)mmol/kgdryweight]. Thesedata suggest that
hypoxia and exercise have an additive effect on insulin
sensitivitywith a greater potential for postexercise glucose
uptake and glycogen synthesis and may therefore provide
a justification for the use ofmoderate hypoxia in the treat-
ment of type 2 diabetes.
HOMAIRandFIRIwere improved in the24hafter each
trial, showing that the combined stress of short-duration
exercise and hypoxia can increase insulin sensitivity. The
current study did not measure muscle glycogen content;
however, it is reasonable tohypothesize that exercise, hyp-
oxia, and an approximately 12-h fast caused glycogen de-
pletion (8, 29). Furthermore, glycogen synthase activity is
increased after 60 min of moderate-intensity exercise
(90% LT) (34). This effect appears to be reversed within
48 h ofHy Ex20 because variables reflecting glycemic con-
trol returned to baseline values. Exercise lasting 40min in
hypoxia also demonstrated improvements in insulin sen-
sitivity extending to 48 h after exercise. The decrease in
insulin resistance shown in the Hy Ex60 trial was greater
when compared with Hy Ex40. Combined, these finding
TABLE 4. Fasting indices of glucose tolerance, insulin secretion, insulin sensitivity, and insulin resistance for the Hy
Ex20 trial
Hypoxic Exercise (Hy Ex20)
Glucose (mmol/liter) Insulin (U/ml) HOMAIR HOMA-Cell QUICKI FIRI
d 1 8.44 (0.56) 14.1 (1.8) 5.24 (0.66) 60.5 (10.9) 0.302 (0.005) 4.72 (0.59)
d 2 7.41 (0.55)a 11.6 (1.3) 3.76 (0.35)a 64.4 (11.0) 0.373 (0.010) 3.39 (0.32)a
d 3 7.98 (0.58) 13.9 (1.7) 5.06 (0.63) 63.7 (7.8) 0.305 (0.015) 4.55 (0.84)
Values are mean (SEM).
a Significantly difference from d 1 (P  0.05).
TABLE 3. Fasting indices of glucose tolerance, insulin secretion, insulin sensitivity, and insulin resistance for the Hy
Ex40 trial
Hy Ex40
Glucose (mmol/liter) Insulin (U/ml) HOMAIR HOMA-Cell QUICK FIRI
d 1 8.53 (0.43) 14.4 (1.0) 5.51 (0.67) 57.7 (3.1) 0.300 (0.004) 4.96 (0.60)
d 2 7.37 (0.33)a 10.8 (0.5)a 3.53 (0.18)a 57.6 (6.5) 0.317 (0.002)a 3.17 (0.16)a
d 3 7.66 (0.23)a 12.0 (0.7) 4.04 (0.28)a 60.3 (5.2) 0.312 (0.003)a 3.63 (0.26)a
Values are mean (SEM).
a Significantly difference from d 1 (P  0.05).
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propose that exercise duration in hypoxia, and not total
work, facilitate greater improvements in moderate-term
glucose control.
Interestingly, both glucose Rd andMCRwere not differ-
entbetweend1and2foranyofthetrials.Thesedataarehard
to explain given that improvements in insulin sensitivity and
decreased fasting glucose were seen. These results may sug-
gest that the improvements in insulin sensitivity are likely the
result of increased systemic insulin action (efficiency) on glu-
coseuptake foragiven insulin concentration,becauseboth
fasting glucose and insulin concentrations were reduced.
In addition, the homeostatic feedback relationship be-
tween insulin sensitivity and insulin secretion suggests that
the improvement in insulin sensitivity would potentially
result in a decrease in insulin requirements and insulin
release due to elevated insulin-stimulated glucose clear-
ance. This can be supported elsewhere with hypoxia- and
exercise-induced improvements in acute insulin response
to an iv glucose challenge (5).
The mechanisms responsible for improvements in
postexercise insulin resistance likely include increased
GLUT-4 membrane content, elevated Akt/protein kinase
B activity and AS160 phosphorylation (35). By complet-
ing the same amount of work in a shorter duration, the
exercise intensities within the present study progressively
increased. Chen et al. (28) reported that AMPK2 activity
increases in an intensity-dependent manner during exer-
cise. AMPK activity is tightly regulated by a number of
factors including blood glucose (36) and insulin concen-
trations (37), free AMP (17), and muscle glycogen (32).
Given the collective findings above, it could be expected
that improvements in postexercise insulin sensitivity
wouldhavebeengreaterwith increasing exercise intensity.
The findings from the current work refute this notion,
because the total amount of work completed between tri-
als was equal. Treebak et al. (35) demonstrated that phos-
pho-AS160 increased during moderate exercise, which
was not evident in a shorter high-intensity bout, suggest-
ing exerciseduration is thekeydeterminate for stimulating
signaling mechanisms involved in GLUT-4 translocation.
One critique of this study is the lack of a control group
exercising under normoxic conditions. Comparing inten-
sity of exercise between normoxic and hypoxic conditions
is complicated by a shift of about 10% in relative intensity
(33).We previously showed in a companion study thatHy
Ex60 gave a greater positive response in terms of glucose
homeostasis than matched workload and duration of ex-
ercise in normoxic conditions in the same group of par-
ticipants and using near-identical methodologies (5). The
primary aim of this study was to investigate the effect of
exercise intensity, independent of work completed, on in-
sulin homeostasis after exercise in hypoxia. Thus, the aim
here was to make comparisons between varying exercise
intensities in hypoxia, not between normoxic and hypoxic
exercise.
The major findings were that moderate-intensity exer-
cise in hypoxia stimulates acute and moderate-term im-
provements in insulin sensitivity. It appears that high-in-
tensity exercise of shorter duration and of equal work (Hy
Ex20) causes improvements in HOMAIR and FIRI; how-
ever, these improvements were more apparent during Hy
Ex60 andHyEx40, showing that exercise duration and not
total work has a greater influence on acute andmoderate-
term glucose control in type 2 diabetics.
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